Know Cancer

or
forgot password
  • cancer clinical trials in greensboro, NC

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
    Regional Center for Infectious Disease, Wendover Medical Center CRS
    Greensboro, North Carolina 27401
    HIV Infections, Sexually Transmitted Diseases
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Endometrial Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    Urology Center
    Greensboro, North Carolina 27401
    Prostate Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Kidney Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Colorectal Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Brain and Central Nervous System Tumors
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Moses Cone Reg Cncr Ctr
    Greensboro, North Carolina 27403
    Non-Small Cell Lung Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer, Fatigue, Hypothyroidism
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lung Cancer
    Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lymphoma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lung Cancer
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Moses Cone Health System - Regional Cancer Center
    Greensboro, North Carolina 27403
    Breast Cancer
    Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer, Menopausal Symptoms
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Strategic Timing of Antiretroviral Treatment
    Regional Center for Infectious Disease
    Greensboro, North Carolina 27401-1209
    HIV Infection
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    Piedmont Respiratory Research Foundation
    Greensboro, North Carolina 27310
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lung Cancer
    Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
    The Moses H. Cone Regional Cancer Center
    Greensboro, North Carolina 27403
    Metastatic Breast Cancer
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Prostate Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Endometrial Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Melanoma (Skin)
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Colorectal Cancer, Precancerous Condition
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Leukemia
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Kidney Cancer
    Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Colorectal Cancer
    Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Colorectal Cancer, Diarrhea, Neutropenia
    Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
    10004: Moses H. Cone Regional Cancer Center
    Greensboro, North Carolina 27403
    Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Tesetaxel as First-line Therapy for Metastatic Breast Cancer
    The Moses H. Cone Regional Cancer Center
    Greensboro, North Carolina 27403
    Breast Neoplasm
    Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
    Moses Cone Regional Cancer Center
    Greensboro, North Carolina 27403
    Diffuse Large B-Cell Lymphoma, Lymphoma, Diffuse Large-Cell, Diffuse Large-Cell Lymphoma, Lymphoma
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Cone Health Cancer Center
    Greensboro, North Carolina
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
    Moses Cone Health System-Regional Cancer Center
    Greensboro, North Carolina 27403
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Alliance Urology Specialists, PA
    Greensboro, North Carolina 27403
    Prostatic Neoplasms
    Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
    Cone Health Cancer Center
    Greensboro, North Carolina
    Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
    The Moses Cone Regional Cancer Center
    Greensboro, North Carolina 27403
    Colorectal Cancer Metastatic
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Head and Neck Cancer, Precancerous Condition
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Cone Health Cancer Center
    Greensboro, North Carolina
    Metastatic Pancreatic Adenocarcinoma
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Moses Cone Regional Cancer Center at Wesley Long Community Hospital
    Greensboro, North Carolina 27401
    Arthralgia, Breast Cancer, Pain
    Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
    Alliance Urology Specialists
    Greensboro, North Carolina 27403
    Bladder Cancer
    Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
    LeBauer Research Associates, PA
    Greensboro, North Carolina 27403
    Ulcerative Colitis